Guillermo Sanz je proslijedio/a tweet korisnika/ceJustin Taylor
A new promising drug for #patients with TP53 mutations & myeloid malignancies #MDS #AML 

@HematoLaFe @HospitalLaFe @HarmonynetEU @sehh_es @_pethema @asleuval @TPHLaFe @Aspanion @ASH_hematology @ASHClinicalNews @MikkaelSekeres @BldCancerDoc @DrMiguelPerales @mrinal90151372https://twitter.com/TaylorJ_MD/status/1222928310960824325 …
Guillermo Sanz je dodan/na,
Justin Taylor @TaylorJ_MD
Aprea Therapeutics Receives FDA Breakthrough Therapy Designation for APR-246 in Combination with Azacitidine for the Treatment of Myelodysplastic Syndromes #MDS with a TP53 Mutation | #leusm https://www.biospace.com/article/releases/aprea-therapeutics-receives-fda-breakthrough-therapy-designation-for-apr-246-in-combination-with-azacitidine-for-the-treatment-of-myelodysplastic-syndromes-mds-with-a-tp53-mutation/?TrackID=16 … #jobs
00:17 - 1. velj 2020.
0 replies
9 proslijeđenih tweetova
25 korisnika označava da im se sviđa
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.